Press news

Mid Atlantic Bio Angels Invests in Veterinary Biotech Company Hilltop Bio

Mid Atlantic Bio Angels, a NY-based angel investor group, is investing in Hilltop Bio, a veterinary biotech company. The MABA investment includes individual investors; MABA’s internal investment Pool III; and the MABA Sidecar Fund II, a co-investment fund for non-MABA members

Hilltop Bio’s products, in development and commercialized, are regenerative therapies that help reduce pain, inflammation, healing time, scar tissue, and reinjury rates. Equine and small animal veterinarians benefit due to the ease of everyday use, storage, and consistent product profile. Veterinarians can also reduce the number of visits a client makes [ Read more… ]

2023-04-08T20:05:54+00:00March 31st, 2023|

MABA Invests in 3D Shape Sensing Technology

NEW YORK CITY, NEW YORK, UNITED STATES, November 10, 2022 /EINPresswire.com/ — Mid Atlantic Bio Angels Group (MABA) is pleased to announce that it has made an investment in The Shape Sensing Company (TSSC).

TSSC joins a prestigious, carefully selected, group of companies and organizations that reflects MABA’s core mission of supporting early-stage health care entrepreneurs and generating favorable financial returns for its members and investors. The MABA investment included individual investors, MABA’s internal investment Pool III, and the MABA Sidecar Fund II, a co-investment fund for non-MABA members.

“Throughout our due diligence process, TSSC’s strong management and transformative technology received notable [ Read more… ]

2023-04-08T20:09:41+00:00November 11th, 2022|

Digital RESI Angel Investor Panel

MABA founder Yaniv Sneor participates on an Angel Investors Panel at Digital RESI 2020 where he discusses several topics including what angels (and MABA) look for in a company, how angels prefer to invest (priced rounds, not SAFEs), and the benefits of syndication.

Link to article: https://blog.lifesciencenation.com/2022/07/14/from-mid-size-pharma-to-angels-what-do-investors-say-about-market-downturn/

2023-04-08T20:09:42+00:00July 14th, 2022|

MABA-backed company, Healionics, awarded the 2022 Luis Villalobos Award from the Angel Capital Association

MABA portfolio company, Healionics, wins the 2020 Luis Villalobos Award from the Angel Capital Association (ACA). The Luis Villalobos Award recognizes ingenious and innovative ideas financed by members of the ACA. Healionics is developing a product to make dialysis safer for those with kidney failure.

Link to document

2023-04-08T20:09:43+00:00May 18th, 2022|
Go to Top